Clinical Trial Update: Safety and Tolerability of Intravenous Administration of ICVB-1042 [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability assessment of intravenous ICVB-1042 in patients with solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ICVB-1042 (ICVB-1042)

Snippet

Sponsor: IconOVir Bio | Conditions: Patients With Advanced Solid Tumors | Phase 1 | Status: TERMINATED